直肠癌在线自适应MR引导放疗在1.5T MR-linac上的可行性
215次计划中有204次在MR-linac上完成,所有计划临床可接受,中位室内时间48分钟,无因患者不耐受而取消或中断,缩小 margins 后CTV覆盖良好。
要点
- 1.5T MR-linac上每日在线重轮廓与重计划行直肠癌放疗可行,中位每分次48分钟。
- 215次计划中204次在MR-linac上完成,无因患者不耐受取消或中断。
核心结论
- 在1.5T MR-linac上对直肠癌行每日在线重轮廓与重计划的MR引导放疗可行,目前每分次约需48分钟。
主要发现
- 215次计划中有204次在MR-linac上完成,所有完成计划均临床可接受。
- 每分次中位室内时间为48分钟(四分位距8)。
- 无分次因患者不耐受而取消或中断。
- 缩小 margins 后CTV覆盖在所有治疗后扫描中良好,仅1例因排气例外。
关键数值与推荐
- 每分次获取3D T2加权MR序列,基于预计划CT轮廓的可变形配准后适应CTV,再行全在线重计划,随后获取新3D T2加权MR序列用于位置验证,并交付5野IMRT计划。
临床怎么用
- 该工作流可用于直肠癌每日在线自适应MR引导放疗,治疗时间约48分钟每分次,支持缩小 margins 的CTV覆盖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Daily online adaptation of the clinical target volume (CTV) using MR-guided radiotherapy enables margin reduction of the planning target volume (PTV). This study describes the implementation and initial experience of MR-guided radiotherapy on the 1.5T MR-linac and evaluates treatment time, patient compliance, and target coverage, including an initial assessment of margin reduction. MATERIALS AND METHODS: Patients were treated on a 1.5T MR-linac (7MV, FFF). At each fraction a 3D T2 weighted (T2w) MR-sequence was acquired on which the CTV was adapted after a deformable registration of the contours from the pre-planning CT scan. Based on the new contours a full online replanning was done after which a new 3D T2w MR-sequence was acquired for position verification. A 5 field Intensity Modulated Radiotherapy (IMRT) plan was delivered. RESULTS: Forty-three patients with rectal cancer were treated with 25 Gy in 5 fractions of which 18 with reduced margins. In total, 204 of 215 fractions were delivered on the MR-linac all of which obtained a clinically acceptable treatment plan. Median in-room time per fraction was 48 min (interquartile range 8). No fractions were canceled or interrupted because of patient intolerance. CTV coverage after margin reduction was good on all post-treatment scans but one due to passing gas. CONCLUSION: MR-guided radiotherapy using daily full online recontouring and replanning on a 1.5T MR-linac for rectal cancer is feasible and currently takes about 48 min per fraction.
引用
- Intven MPW, de Mol van Otterloo SR, Mook S, et al. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience. Radiother Oncol. 2020. PMID: 32976875. doi:10.1016/j.radonc.2020.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。